An open, randomized, three-way crossover study assessing the effect of food intake on the pharmacokinetics (PK) and tolerability of single oral administration of YH4808 in healthy Korean volunteers.

Trial Profile

An open, randomized, three-way crossover study assessing the effect of food intake on the pharmacokinetics (PK) and tolerability of single oral administration of YH4808 in healthy Korean volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Apr 2016

At a glance

  • Drugs YH 4808 (Primary)
  • Indications Gastro-oesophageal reflux
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 22 Apr 2016 New trial record
    • 12 Mar 2016 Results presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top